Revenue Estimates Analysis of Cosan Limited(NYSE:CZZ): Ampio Pharmaceuticals, Inc.(NYSE:AMPE)

0
2

Many analysts are providing their Estimated Earnings analysis for Cosan Limited and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Cosan Limited might touch $13.6 high while the Average Price Target and Low price Target is $11.54 and $9.1 respectively.

Cosan Limited closed its last trading session at $8.67 with the gain of 0%. The Market Capitalization of the company stands at 1.93 Billion. The Company has 52-week high of $11.89 and 52-week low of $6.20. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 8.14% where SMA50 and SMA200 are 10.61% and 0.19% respectively. The Company Touched its 52-Week High on 02/21/18 and 52-Week Low on 09/11/18.

The Relative Volume of the company is 1.21 and Average Volume (3 months) is 1.27 million. The company’s P/E (price to earnings) ratio is 12.49 and Forward P/E ratio of 9.89.

The company shows its Return on Assets (ROA) value of 1.3%. The Return on Equity (ROE) value stands at 11.6%. While it’s Return on Investment (ROI) value is 11.5%.

While looking at the Stock’s Performance, Cosan Limited currently shows a Weekly Performance of 12.74%, where Monthly Performance is 0.93%, Quarterly performance is 33.18%, 6 Months performance is -0.34% and yearly performance percentage is -7.77%. Year to Date performance value (YTD perf) value is -10.62%. The Stock currently has a Weekly Volatility of 3.93% and Monthly Volatility of 4.20%.

Many analysts are providing their Estimated Earnings analysis for Ampio Pharmaceuticals, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Ampio Pharmaceuticals, Inc. closed its last trading session at $0.65 with the gain of 0%. The Market Capitalization of the company stands at 70.43 Million. The Company has 52-week high of $4.95 and 52-week low of $0.35. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 9.2% where SMA50 and SMA200 are 22.93% and -61.99% respectively. The Company Touched its 52-Week High on 12/29/17 and 52-Week Low on 08/09/18.

The Relative Volume of the company is 3.64 and Average Volume (3 months) is 1.55 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 381%. The Return on Equity (ROE) value stands at -489.2%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Ampio Pharmaceuticals, Inc. currently shows a Weekly Performance of 4.02%, where Monthly Performance is 40.02%, Quarterly performance is 20.39%, 6 Months performance is -64.86% and yearly performance percentage is -60.84%. Year to Date performance value (YTD perf) value is -84.03%. The Stock currently has a Weekly Volatility of 11.66% and Monthly Volatility of 12.96%.

SHARE